US FDA approves TG Therapeutics’ multiple sclerosis drug
The approval by the US Food and Drug Administration (USFDA) widens the number of such drugs available for treating the disorder to…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
TG Therapeutics
FDA withdraws approval for TG Therapeutics cancer treatment
The withdrawal has been due to concerns of higher risk of death in patients receiving the drug
Rhizen Pharma’s partnered asset Umbralisib gets US FDA accelerated nod for relapsed or…
Umbralisib is a novel, next generation, oral, once daily, inhibitor of phosphoinositide 3 kinase (PI3K) delta and casein kinase 1…